All Articles

ORIX restructures its global operations, tapping Terry Suzuki to lead a new USA & Europe unit aimed at accelerating its 2035 vision and asset growth.

BridgeBio Pharma hosts a key investor webinar on its oral drug infigratinib for achondroplasia, setting the stage for crucial trial results in Q1 2026.

Clicks Technology launches a smartphone with a physical keyboard, betting that users want a focused companion for communication, not another distraction.

As Byline Bancorp nears a key $10B asset threshold, all eyes are on its Q4 results to see if its strong performance can overcome market headwinds.

With its acquisition of Lantheus' SPECT business, SHINE Technologies is creating a vertically integrated powerhouse to end isotope shortages.

As robotaxis and self-driving trucks go commercial, a new group from Seeing Machines aims to solve the critical human trust and safety challenge.

Tire giant Michelin buys advanced materials firm Tex-Tech to fuel its diversification, as a new defense-focused composite entity, FMI, is spun off.

Fresh off a major drug approval, Insmed's upcoming J.P. Morgan talk is under scrutiny as investors eye pipeline updates and acquisition potential.

The acquisition of seven Kloeckner service centers marks a major strategic push, expanding Russel Metals' U.S. footprint and value-added capabilities.

The organic retailer's third Wyoming store will create jobs with competitive pay and shake up the local grocery market when it opens this spring.

Cactus completes its acquisition of a 65% stake in Baker Hughes's SPC unit, a transformational move set to expand its global footprint and reshape the market.

A price increase on critical specialty chemicals by Trecora reveals mounting cost pressures that could ripple through automotive, construction, and water treatment.

SmartCentres extends CEO talks, but the end of its founder's special voting rights signals a new era of governance and uncertainty for the REIT's future.

Nouveau Monde Graphite issues stock to pay interest to its major investor, Investissement Québec, highlighting a strategy to conserve cash for key projects.

Ironwood Pharma forecasts a massive profit jump by lowering its top drug's price, a bold move as it advances its rare disease pipeline for future growth.

With patent cliffs looming and big bets on M&A, all eyes are on BMS to prove its growth strategy and high-stakes pipeline can deliver in 2026.

RPM International's 52nd straight year of dividend hikes cements its 'Dividend King' status. We look at the strategy behind this rare achievement.

Global tech firm Affle appoints Sameer Sondhi to a dual leadership role, signaling a major push for market share and strategic acquisitions in North America.

Shipping giant Costamare Inc. reaffirms its financial strength with consistent shareholder payouts, backed by a strong market and strategic growth.

Cannara Biotech rockets to #1 in Québec's cannabis market, fueled by a smash-hit vape launch, while also moving to overhaul its corporate governance.